Report for: Disease Control Implications of India's Changing Multi-Drug Resistant Tuberculosis Epidemic

Title	Disease Control Implications of India's Changing Multi-Drug Resistant Tuberculosis Epidemic
Published in	PLOS ONE, March 2014
DOI	10.1371/journal.pone.0089822
Pubmed ID	24608234
Authors	Sze-chuan Suen, Eran Bendavid, Jeremy D. Goldhaber-Fiebert
Abstract	Multi-drug resistant tuberculosis (MDR TB) is a major health challenge in India that is gaining increasing public attention, but the implications of India's evolving MDR TB epidemic are poorly understood. As India's MDR TB epidemic is transitioning from a treatment-generated to transmission-generated epidemic, we sought to evaluate the potential effectiveness of the following two disease control strategies on reducing the prevalence of MDR TB: a) improving treatment of non-MDR TB; b) shortening the infectious period between the activation of MDR TB and initiation of effective MDR treatment.

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
United States	1	25%
Unknown	3	75%

Type	Count	As %
Members of the public	4	100%

Mendeley readers

The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Readers by professional status	Count	As %
Student > Master	19	17%
Researcher	17	15%
Student > Ph. D. Student	17	15%
Student > Postgraduate	9	8%
Student > Bachelor	9	8%
Other	20	18%
Unknown	22	19%

Readers by discipline	Count	As %
Medicine and Dentistry	35	31%
Social Sciences	9	8%
Mathematics	6	5%
Nursing and Health Professions	5	4%
Immunology and Microbiology	4	4%
Other	22	19%
Unknown	32	28%

PLOS